Jump to content

Epidemija koronavirusa (Covid-19 / SARS-Cov2) - dnevne aktuelnosti iz zemlje i sveta


djole
Message added by Eddard

Dragi forumaši, molimo vas da u vreme ove krize ostanemo prisebni i racionalni i da pisanjem na ovoj temi ne dođemo u situaciju da naudimo nekome. Stoga:

 

- nemojte davati savete za uzimanje lekova i bilo kakvu terapiju, čak i ako ste zdravstveni radnik - jedini ispravni put za sve one koji eventualno osećaju simptome je da se jave svom lekaru ili na neki od telefonskih brojeva koji su za to predviđeni.

- takođe - ne uzimajte lekove napamet! Ni one proverene, ni one potencijalne - obratite se svom lekaru!

- nemojte prenositi neproverene informacije koje bi mogle nekoga da dovedu u zabludu i eventualno mu načine štetu. Znamo da je u moru informacija po pitanju ove situacije jako teško isfiltrirati one koje su lažne, pogrešne ili zlonamerne, ali potrudite se - radi se o zdravlju svih nas. Pokušajte da informacije sa kojekakvih obskurnih sajtova i sumnjivih izvora ne prenosite. Ili ih prvo proverite pre nego što ih prenesete.

- potrudite se da ne dižete paniku svojim postovima - ostanimo mirni i racionalni.

- aktivno propagiranje naučno neutemeljenih (između ostalih i antivaxxerskih) stavova i pozivanje na nevakcinisanje bazirano na njima nećemo tolerisati.

 

Budimo dostojanstveni u ovoj krizi, ovakve situacije su ogledalo svih nas. 

Hvala na razumevanju.

 

Vaš tim Vox92

Vakcinacija  

194 members have voted

  1. 1. Da li ste vakcinisani protiv Coronavirus-a i kojom vakcinom?

    • Pfizer/Biontech
    • Sinopharm
    • Sputnik V
    • Moderna
    • AstraZeneca/Oxford
    • Johnson & Johnson
    • Nisam i ne želim da se vakcinišem
    • Nisam još sigurna/an da li ću se vakcinisati
    • Preležao/la sam Covid-19, pa čekam da vidim da li i kada ću da se vakcinišem


Recommended Posts

Sto se tice "superspreder" eventova gde su skoro svi asimptomatski, trebalo bi konacno posle dve jebene godine odraditi eksperiment i testirati grupu ljudi kao kontrolnu cisto da konacno vidimo koliko je PCR pouzdan. Sve ove predikcije i "potentnost" Omikrona vrlo moguce leze u PCR testu.

 

Link to comment
Share on other sites

1 hour ago, Clash said:

Moderacijo, aj neko novo glasanje odje. Moramo raditi update našeg istraživanja, ne mogu stari podaci doveka.

Nešto tipa jeste li preležali, jeste li se bustovali, smislite nešto, nismo vas džaba birali za šerife.

@Eddard

 

Koji ce nam ocin, kad cemo svi pomreti od omicrona - i bustovani i nebustovani i prelezali i neprelezali!

 

Bilo mi je drago druziti se s vama!

 

(Ko je vas poznavao, ni pakao mu nece tesko pasti!) 

  • Like 1
  • Love 2
  • Ha-ha 8
  • Tuzno 1
Link to comment
Share on other sites

2 minutes ago, Sunshine State said:

 

Koji ce nam ocin, kad cemo svi pomreti od omicrona - i bustovani i nebustovani i prelezali i neprelezali!

 

Bilo mi je drago druziti se s vama!

 

(Ko je vas poznavao, ni pakao mu nece tesko pasti!) 

Ono jes, neki  cete izginete a neki koji su primili dva Sputnjika i bustovali Fajzerom na Novom Naselje u nedelju posle podne, ne znam tacno koji datum ce i da prezive.

  • Ha-ha 2
Link to comment
Share on other sites

27 minutes ago, Clash said:

Ono jes, neki  cete izginete a neki koji su primili dva Sputnjika i bustovali Fajzerom na Novom Naselje u nedelju posle podne, ne znam tacno koji datum ce i da prezive.

 

Sad kad ti erwin izvuce neki graf gde se vidi da je kod 78.345 % takvih izraslo trece uvo na nosu!

  • Like 2
  • Ha-ha 4
Link to comment
Share on other sites

Fajzer i Biontek kažu da 3 doze neutrališu, 2 i dalje verovatno štite od teških oblika bolesti.

 

Quote

PFIZER AND BIONTECH PROVIDE UPDATE ON OMICRON VARIANT
Wednesday, December 08, 2021 - 06:54am


- Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers
- Data indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection
- As 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease
- The companies continue to advance the development of a variant-specific vaccine for Omicron and expect to have it available by March in the event that an adaption is needed to further increase the level and duration of protection – with no change expected to the companies’ four billion dose capacity for 2022


NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced results from an initial laboratory study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from vaccinees one month after receiving the booster vaccination (third dose of BNT162b2 vaccine) neutralized the Omicron variant to levels that are comparable to thoseobserved for the wild-type SARS-CoV-2 spike protein after two doses.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211208005542/en/

Sera from individuals who received two doses of the current COVID-19 vaccine did exhibit, on average, more than a 25-fold reduction in neutralization titers against the Omicron variant compared to wild-type, indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant. However, as the vast majority of epitopes targeted by vaccine-induced T cells are not affected by the mutations in Omicron, the companies believe that vaccinated individuals may still be protected against severe forms of the disease and are closely monitoring real world effectiveness against Omicron, globally.

A more robust protection may be achieved by a third dose as data from additional studies of the companies indicate that a booster with the current COVID-19 vaccine from Pfizer and BioNTech increases the antibody titers by 25-fold. According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron. These antibody levels are associated with high efficacy against both the wild-type virus and these variants. A third dose also strongly increases CD8+ T cell levels against multiple spike protein epitopes which are considered to correlate with the protection against severe disease. Compared to the wild-type virus, the vast majority of these epitopes remain unchanged in the Omicron spike variant.

“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”

“Our preliminary, first dataset indicate that a third dose could still offer a sufficient level of protection from disease of any severity caused by the Omicron variant,” said Ugur Sahin, M.D., CEO and Co-Founder of BioNTech. “Broad vaccination and booster campaigns around the world could help us to better protect people everywhere and to get through the winter season. We continue to work on an adapted vaccine which, we believe, will help to induce a high level of protection against Omicron-induced COVID-19 disease as well as a prolonged protection compared to the current vaccine.”

While these results are preliminary, the companies will continue to collect more laboratory data and evaluate real-world effectiveness to assess and confirm protection against Omicron and inform the most effective path forward. On November 25, the companies started to develop an Omicron-specific COVID-19 vaccine. The development will continue as planned in the event that a vaccine adaption is needed to increase the level and duration of protection against Omicron. First batches of the Omicron-based vaccine can be produced and are planned to be ready for deliveries within 100 days, pending regulatory approval. Pfizer and BioNTech have tested other variant-specific vaccines as well, which have produced very strong neutralization titers and a tolerable safety profile. Based on this experience the companies have high confidence that if needed they can deliver an Omicron-based vaccine in March 2022. The companies have also previously initiated clinical trials with variant-specific vaccines (Alpha, Beta, Delta & Alpha/Delta Mix) and data from these studies will be submitted to regulatory agencies around the world to help accelerate the process of adapting the vaccine and gaining regulatory authorization or approval of an Omicron-specific vaccine, if needed. The companies have previously announced that they expect to produce four billion doses of BNT162b2 in 2022, and this capacity is not expected to change if an adapted vaccine is required.

About the Pfizer-BioNTech Laboratory Studies

To evaluate the effectiveness of BNT162b2 against the Omicron variant, Pfizer and BioNTech immediately tested a panel of human immune sera obtained from the blood of individuals that received two or three 30-µg doses of the current Pfizer-BioNTech COVID-19 vaccine, using a pseudovirus neutralization test (pVNT The sera were collected from subjects 3 weeks after receiving the second dose or one month after receiving the third dose of the Pfizer-BioNTech COVID-19 vaccine. Each serum was tested simultaneously for its neutralizing antibody titer against the wild-type SARS-Cov-2 spike protein, and the Omicron spike variant. The third dose significantly increased the neutralizing antibody titers against the Omicron strain spike by 25-fold. Neutralization against the Omicron variant after three doses of the Pfizer-BioNTech COVID-19 vaccine was comparable to the neutralization against the wild-type strain observed in sera from individuals who received two doses of the companies’ COVID-19 vaccine: The geometric mean titer (GMT) of neutralizing antibody against the Omicron variant measured in the samples was 154 (after three doses), compared to 398 against the Delta variant (after three doses) and 155 against the ancestral strain (after two doses). Data on the persistence of neutralizing titers over time after a booster dose of BNT162b2 against the Omicron variant will be collected.

The Pfizer-BioNTech COVID-19 vaccine, which is based on BioNTech’s proprietary mRNA technology, was developed by both BioNTech and Pfizer. BioNTech is the Marketing Authorization Holder in the United States, the European Union, the United Kingdom, Canada and other countries and the holder of emergency use authorizations or equivalents in the United States (jointly with Pfizer) and other countries. Submissions to pursue regulatory approvals in those countries where emergency use authorizations or equivalent were initially granted are planned.

https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-provide-update-omicron-variant

  • Like 2
Link to comment
Share on other sites

Piše da su testirali mesec dana od treće, čisto sumnjam da nisu testirali i uzorke onih koji su buster primili ranije (pre 2 ili 3 meseca) pa došli do nepovoljnijih rezultata koje ne bi hteli da objave.

 

I uglavnom, uvek ću pre verovati nezavisnim ispitivanjima nego onima koje obavljaju sami proizvođači, a onda saopštavaju samo one rezultate koji im odgovaraju.

Edited by erwin
  • Like 1
Link to comment
Share on other sites

2 hours ago, Sunshine State said:

 

Koji ce nam ocin, kad cemo svi pomreti od omicrona - i bustovani i nebustovani i prelezali i neprelezali!

 

Bilo mi je drago druziti se s vama!

 

(Ko je vas poznavao, ni pakao mu nece tesko pasti!) 

 

Znaci da bi bio siguran od omikronare, treba da si prelezao, sto skorije i sto teze po mogucstvu + 2 doze Fajzera i buster Sinofarm, pa nakon 3 meseca Sputnjik, i onda si DOBAR. 

  • Ha-ha 3
Link to comment
Share on other sites

On 12/6/2021 at 4:36 PM, Sunshine State said:

Samo briga!

 

Sad mi mama javlja da prijateljicin sin (47 god, dva Sinopharma, buster Pfizer) od prekjuce ima temperaturu, danas isao kod lekara, CRP 201 (!), i upala pluca (rendgen), a antigen negativan (PCR rezultat sutra); ostaje u bolnici.

 

Mama i ta prijateljica svaki dan piju kafu zajedno.... juce su bile zajedno.... sad valja iscekati nekoliko dana da vidimo sta ce biti 😞

 

Update:

 

Juce dobio PCR, negativan, "upala pluca se povukla, CRP spada", danas ide kuci kako su mu rekli "da se ne bi razboleo u bolnici"

 

Ja ne mogu da verujem da coveku, uz onakav rezultat urina i CRPod 200, ne dijagnostikuju urinarnu infekciju, vec ga strpaju u bolnicu u "narandzastu zonu" (mogucnost zarazavanja tamo) i onda zakljuce da se infekcija smiruje uz antibiotike! Alooo, pa naravno, kad je bila bakterijska infekcija!

 

  • Like 1
  • Tuzno 3
Link to comment
Share on other sites

U Svedskoj, s izuzetkom par slabije naseljenih regiona, jos uvek nista od trece doze za nas omladince i omladinke ispod 65. Od juce kao vratili neke preporuke, rad od kuce i maske u javnom prevozu, i to je to. Broj zarazenih nizak, ali i do testova se tesko dolazi, tako da nije bas verovati statistici.

U nedostatku trece doze, moj poslodavac nam danas ponudio besplatnu vakcinu protiv sezonskog gripa, pa sam se bocnula. Isto boli ruka i udara u glavu, pa se sad pitam sta mi je to trebalo, ali rekoh daj sta das 😀.

Link to comment
Share on other sites

3 minutes ago, vilhelmina said:

U Svedskoj, s izuzetkom par slabije naseljenih regiona, jos uvek nista od trece doze za nas omladince i omladinke ispod 65. Od juce kao vratili neke preporuke, rad od kuce i maske u javnom prevozu, i to je to. Broj zarazenih nizak, ali i do testova se tesko dolazi, tako da nije bas verovati statistici.

U nedostatku trece doze, moj poslodavac nam danas ponudio besplatnu vakcinu protiv sezonskog gripa, pa sam se bocnula. Isto boli ruka i udara u glavu, pa se sad pitam sta mi je to trebalo, ali rekoh daj sta das 😀.

 

I u Holandijji broj testiranja smanjen, ali to je zato sto vlada traži od ljudi da idu u GGD (zdravstvene ustanove/test) samo ako imaju simptome i prvo su uradili samotestiranje sa pozitivnim rezultatom ili ako im se simptomi pogoršaju.

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...